logo
15:59 Mar 13

Glenmark Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1405.15
-17.15 (-1.21%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Glenmark Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals 15:59 Mar 13
Up
1405.15
-17.15 (-1.21%)
image/svg+xml

28/100 Low Financial Strength

Quality
image/svg+xml

11/100 Expensive Valuation

Valuation

39/100 Technically Neutral

Technical

SWOT

Strength

5

Weakness

5

Opportunity

1

Threat

0

39.65K

Market Cap (Cr)

-225.50

PE Ratio

4.69

Price to Book Ratio

51.66

RSI

-12.71 %

Net Profit Margin

Rating Based on 4 Analysts

Buy 50%
Hold 25%
Sell 25%
Buy
The consensus recommendation from 2 analysts for Glenmark Pharmaceuticals Ltd. is Buy

Analyst Price Target

The average price target is 1702.25 with a high estimate of 1894 and low estimate of 1345
Current 1405.15
1894.00
1702.25
1345.00
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation

SWOT

  • Good quarterly growth in the recent results
  • Company with Low Debt
  • Company with Zero Promoter Pledge
  • Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
  • Stock with Low PE (PE < = 10)

Checklist

10 12 1
  • Yes
  • No
  • Neutral

Financials

  • Company has seen consistent profit growth in the last eight quarters?
  • Company has seen consistent sales growth in the last eight quarters?
  • Company has high Trendlyne Durability Score?
  • Company has high Piotroski Score?
  • Company has Low Debt?
  • Shareholder Value: Company has Strong ROE?
  • Company has Positive Net Cash Flow?
  • Company is generating increasing cash from operations?

Ownership

  • FII/FPI or DIIs are buying the stock?
  • Promoters are buying the stock or ownership is stable?
  • Promoter pledge is low and not increasing?
  • Insiders have not sold stock in the past 3 months?

Peer Comparison

  • Company is giving better long term returns than the industry?
  • Company's sales growth is better than the industry median?
  • Company's profit growth is better than the industry median?

Value And Momentum

  • The stock is in the Buy Zone according to its historical P/E?
  • The stock is in the Buy Zone according to its historical P/BV?
  • Company's valuation score signals overall affordability?
  • Trendlyne Momentum Score shows bullishness?
  • Stock is trading above all short term SMAs?
  • Stock is trading above all long term SMAs?
  • Stock has bullish candlesticks?
  • Stock has active positive breakouts?
qr-code
login-icon

Take your research to the next level.
Login now to unlock Exclusive Features!

login-icon-1

Take your research to the next level.
Login now to unlock Exclusive Features!

Research 360 logo

Download Our App On:

SunMonTueWedThuFriSat
2627282930311234567891011121314151617181920212223242526272829303112345